Evaluation of the Altered Pathophysiological Mechanism of the Human Arg302Gln-PRKAG2 Mutation-Induced Metabolic Cardiomyopathy: Studying the Glucose Metabolism Pathway in a Transgenic Mouse Model
Characterized by excessive myocardial glycogen deposition, cardiac hypertrophy, frequent cardiac arrhythmias and progressive conduction system disease, the PRKAG2 cardiac syndrome stems from a genetic mutation in the γ2-subunit of AMP-activated protein kinase (AMPK). Although functionally diverse,...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/24045 http://dx.doi.org/10.20381/ruor-2946 |